Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-7-30
pubmed:abstractText
We have demonstrated previously that susceptibility of murine strains to the development of allergic airway responses is associated with a type 2 cytokine pattern. In the present study, we examine the in vivo role of IL-12 in the immune response to allergen exposure in susceptible (A/J) and resistant (C3H/HeJ, C3H) strains of mice. OVA sensitization and challenge induced significant increases in airway reactivity in A/J mice as compared with their PBS-challenged controls, while no increases in airway reactivity were observed in OVA-challenged C3H mice. OVA exposure of A/J mice resulted in marked increases in the Th2 cytokines, IL-4 and IL-10, in the bronchoalveolar lavage fluid, whereas increases in IFN-gamma were observed in C3H mice. Strikingly, anti-IL-12 mAb (1 mg/mouse) treatment resulted in threefold increases in airway reactivity in OVA-challenged resistant C3H mice, concomitant with significant increases in bronchoalveolar lavage levels of Th2 cytokines and decreases in IFN-gamma. IL-12 depletion of C3H mice also suppressed OVA-specific serum IgG2a levels and increased both serum OVA-specific IgG1 and IgE levels. Blockade of endogenous IL-12 levels in susceptible A/J mice resulted in further augmentation of type 2 immune responses. These results demonstrate that endogenous production of IL-12 is essential for resistance to Ag-induced airway hyperresponsiveness, and furthermore, that dysregulation of IL-12 production may lead to the development of deleterious type 2 immune responses to inhaled allergens.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
161
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
919-26
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9670970-Animals, pubmed-meshheading:9670970-Antibodies, Monoclonal, pubmed-meshheading:9670970-Bronchial Hyperreactivity, pubmed-meshheading:9670970-Cytokines, pubmed-meshheading:9670970-Disease Susceptibility, pubmed-meshheading:9670970-Epitopes, T-Lymphocyte, pubmed-meshheading:9670970-Immune Sera, pubmed-meshheading:9670970-Immunity, Innate, pubmed-meshheading:9670970-Immunoglobulin E, pubmed-meshheading:9670970-Immunoglobulin G, pubmed-meshheading:9670970-Injections, Intraperitoneal, pubmed-meshheading:9670970-Interleukin-12, pubmed-meshheading:9670970-Lung, pubmed-meshheading:9670970-Male, pubmed-meshheading:9670970-Mice, pubmed-meshheading:9670970-Mice, Inbred A, pubmed-meshheading:9670970-Mice, Inbred C3H, pubmed-meshheading:9670970-Ovalbumin, pubmed-meshheading:9670970-Th2 Cells
pubmed:year
1998
pubmed:articleTitle
Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12.
pubmed:affiliation
Department of Environmental Health Sciences, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, MD 21205, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't